Drug Database
Back to search

Japan· JP-2359701X1018

メチルセルロース

A methylcellulose product containing メチルセルロース, registered in Japan, on the national reimbursement list. The same ATC class is registered in 2 of our 19 countries.

On Japan’s NHI price listATC A06AC06

Checked against MHLW / PMDA (Japan) on

Informational only — not a medical device.

SOURCE REGISTER · JPMHLW / PMDA (Japan)normalisedメチルセルロースATCA06AC06REGISTER NO.JP-2359701X1018PACKS LISTED0CHECKEDSeptember 25, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about メチルセルロースAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Methylcellulose is registered in 2 of 19 countries.

Countries holding a registration under ATC A06AC06 (methylcellulose), each read from that country’s own register.

  • This record: Japan, from MHLW / PMDA (Japan)
Search methylcellulose products by name

Methylcellulose · ATC A06AC06

2 / 19 countries

  • Japan
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

MHLW / PMDA (Japan)
Active substance
メチルセルロース
Manufacturer
—
Country
Japan (JP)
ATC code
A06AC06
ATC class
Methylcellulose
Defined daily dose
2 g, O
Reimbursed
Yes
Source register
MHLW / PMDA (Japan)
Last checked
September 25, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

29 interactions on record for methylcellulose.

Graded by severity as the source publishes them — 2 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check methylcellulose against other medicinesHow interaction checks work

Methylcellulose · interactions on record

29 records

  • 2 moderate
  • 27 minor

Most severe, free to view

  • LactuloseA06AD11moderate
  • Fludeoxyglucose (18F)V09IX04moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same class

Other records under A06AC06

Methylcellulose, as other registers publish it.

All methylcellulose products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d07e8732-b2be-47d9-8b78-0c8c731ffb81
GET /v1/drugs/d07e8732-b2be-47d9-8b78-0c8c731ffb81?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "spec": "１０ｇ",
  "marks": "局",
  "source": "mhlw",
  "remarks": null,
  "yj_code": "2359701X1018",
  "category": "外用薬",
  "price_yen": null,
  "generic_name": "メチルセルロース",
  "product_name_jp": null,
  "therapeutic_class": "2359",
  "transitional_expiry": null
}
API referenceMCP serverPlans

See everything about methylcellulose.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console